(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Peptide Transporters: Structure, Function, Regulation and Application for Drug Delivery
The DOI matches its Crossref record.
Abstract
Proton-coupled peptide transporters, localized at brush-border membranes of intestinal and renal epithelial cells, play important roles in protein absorption and the conservation of peptide-bound amino nitrogen. These transporters also have significant pharmacological and pharmacokinetic relevance to the transport of various peptide-like drugs such as beta-lactam antibiotics. The identification and molecular characterization of H(+)/peptide cotransporters (PEPT1 and PEPT2) have facilitated the clarification of many aspects of these transporters such as the structure/function relationship and regulation. Recent findings that intestinal PEPT1 can transport l-valine ester prodrugs such as valacyclovir provided a major step forward toward the development of novel drug delivery systems. It has been demonstrated that peptide transporters, which have a similar substrate specificity to PEPT1 and PEPT2, but possess other distinct functional properties, are localized at basolateral membranes of intestinal and renal epithelial cells. This review highlights the recent advances in our knowledge of the cellular and molecular nature of PEPT1, PEPT2 and the basolateral peptide transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A significant disadvantage of DFO is that it does not seem to cross the intestine intact (despite the rather catholic substrate specificity of intestinal peptide transporters [1682-1685]) and must therefore be given intravenously or subcutaneously.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1684]
Citations
Cited by
Items 101–178 of 178
Biology of ocular transporters: efflux and influx transporters in the eye
Pal, D., Krishna, V. R., Vadlapudi, A. D., & Mitra, A. K. (2013) · Elsevier eBooks · doi:10.1533/9781908818317.37 · Cited by 16
Utility of transporter/receptor(s) in drug delivery to the eye
Boddu, S. H. S. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i1.1 · Cited by 15
Panitsas, K.-E., Boyd, C. A. R., & Meredith, D. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-0002-0 · Cited by 15
“The peptide transporters also hold considerable interest for pharmacologists as they transport various peptide-like drugs (‘peptidomimetics’) such as the β-lactam antibiotics (see [28] for a review).”
BackgroundGong, Y., Zhang, J., Wu, X., Wang, T., Zhao, J., Yao, Z., Zhang, Q., Liu, X., & Xu, J. C. (2017) · Oncology Letters · doi:10.3892/ol.2017.6724 · Cited by 15
Sun, L., Wu, B., Yan, M., Hou, H., & Zhuang, Y. (2019) · Marine Drugs · doi:10.3390/md17050288 · Cited by 14
Pieri, M., Hall, D., Price, R. A., Bailey, P. D., & Meredith, D. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.010 · Cited by 14
Dipeptidyl Peptidase IV (DPPIV/CD26)‐Based Prodrugs of Hydroxy‐Containing Drugs
Diez‐Torrubia, A., Cabrera, S., Lambeir, A., Balzarini, J. M., Camarasa, M., & Velázquez, S. (2012) · ChemMedChem · doi:10.1002/cmdc.201100504 · Cited by 15
Bailey, P. D., Boyd, C. A. R., Collier, I. D., Kellett, G. L., Meredith, D., Morgan, K. M., Pettecrew, R., & Price, R. A. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b513274f · Cited by 13
Rogers, L. M.-A., McGivern, P. G., Butler, A. R., MacRobert, A. J., & Eggleston, I. M. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.05.036 · Cited by 13
Recent advances in therapeutic applications of human peptide transporters
Nielsen, C. U., Våbenø, J., Andersen, R., Brodin, B., & Steffansen, B. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.2.153 · Cited by 13
“Recent reviews of the literature on peptide transport and transporters may be found in the following references [9-16], which range from physiological to pharmaceutical perspectives.”
BackgroundInfluentialLinks, J. L. S., Kulkarni, A. A., Davies, D. L., Lee, V. H. L., & Haworth, I. S. (2007) · Journal of drug targeting · doi:10.1080/10611860701267491 · Cited by 13
“One such transporter, the human dipeptide transporter (hPepT1), is responsible for dipeptide transport (Daniel 2004; Terada and Inui 2004; Steffansen et al. 2005) and also transports a number of important drugs (Katsura and Inui 2003; Luckner and Brandsch 2005).”
BackgroundMaeda, K. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000966 · Cited by 13
“…1), which intrinsically transports di- and tri-peptides, can also recognize drugs such as penicillins, cephalosporins and angiotensin-converting enzyme (ACE) inhibitors and their bioavailabilities tend to be higher than expected based on their physicochemical properties (Terada and Inui, 2004).”
BackgroundYago, T., Yuda, N., Tanaka, M., Iwao, T., & Matsunaga, T. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114831 · Cited by 12
Molecular Fields to Assess Recognition Forces and Property Spaces
Vistoli, G., & Pedretti, A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00142-5 · Cited by 12
Transporter targeted drug delivery
Mandava, N. K., Oberoi, R. K., Minocha, M., & Mitra, A. (2010) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(10)50012-1 · Cited by 12
Hou, C., Yamaguchi, S., Ishi, Y., Terasaka, S., Kobayashi, H., Motegi, H., Hatanaka, K. C., & Houkin, K. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03158-3 · Cited by 11
Ananth, S., Karunakaran, S. K., Martin, P. M., Nagineni, C. N., Hooks, J. J., Smith, S. B., Prasad, P. D., & Ganapathy, V. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9709-x · Cited by 11
Kusuhara, H., Sekine, T., Anzai, N., & Endou, H. (2014) · Wiley eBooks · doi:10.1002/9781118705308.ch15 · Cited by 11
Intestinal transporters and oral absorption enhancing strategies based on these transporters
Ju, W., Sun, Y., Meng, L., Feng, J., Cheng, M., & Tu, L. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110529 · Cited by 15
Kitamura, K., Kinsui, E. Z. B., & Abe, F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.11.030 · Cited by 10
Noh, K., & Pang, K. S. (2019) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2184 · Cited by 10
“The red and blue areas denote arterial and venous blood, respectively; the green line represents the bile duct & Perez‐Torras, 2018; Terada & Inui, 2004; Tsuji & Tamai, 1996; Wang et al., 1997; L. Zhang, Brett, & Giacomini, 1998) to facilitate apical drug absorption/transport.”
BackgroundConformational and spacial preferences for substrates of PepT1
Bailey, P. D., Boyd, C. A. R., Collier, I. D., George, J. G., Kellett, G. L., Meredith, D., Morgan, K. M., Pettecrew, R., Price, R. A., & Pritchard, R. G. (2005) · Chemical Communications · doi:10.1039/b510697d · Cited by 10
Mitsuoka, K., Kato, Y., Kubo, Y., & Tsuji, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010405 · Cited by 10
“PEPT1 also mediates uptake of various other drugs, including certain angiotensin-converting enzyme inhibitors, an anticancer agent (ubenimex), and an antiviral agent (valacyclovir), as well as dipeptides and tripeptides derived from nutrients (Balimane et al., 1998; Rubio-Aliaga and Daniel, 2002; Tsuji, 2002; Daniel,…”
BackgroundMechanisms of Drug Interactions II: Transport Proteins
Marzolini, C., Battegay, M., & Back, D. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-213-7_3 · Cited by 12
Ji, K., He, J., Liang, H., Ren, M., Ge, X., & Masagounder, K. (2020) · Aquaculture Nutrition · doi:10.1111/anu.13164 · Cited by 9
Role of Multidrug Resistance Associated Proteins in Drug Development
Zhou, S. (2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805292911201010003 · Cited by 10
Biological Transporters as Targets for New Drug Design
Wang, H.-P., & Wang, C. L. (2009) · Journal of Experimental & Clinical Medicine · doi:10.1016/s1878-3317(09)60008-5 · Cited by 9
Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels
Irie, M., Terada, T., Tsuda, M., Katsura, T., & Inui, K. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-0005-x · Cited by 8
Self-citationPedretti, A., Luca, L. D., Marconi, C., Regazzoni, L., Aldini, G., & Vistoli, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.027 · Cited by 7
OKAMURA, M., Terada, T., Katsura, T., & Inui, K. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.464 · Cited by 7
Self-citationAnatomical and Physiological Factors Affecting Oral Drug Bioavailability in Rats, Dogs, and Humans
El‐Kattan, A. F., Hurst, S. I., Brodfuehrer, J., & Loi, C. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch16 · Cited by 9
Zhao, Y., Wang, H., Chen, D., Tian, G., Zheng, P., Pu, J., & Yu, B. (2024) · LWT · doi:10.1016/j.lwt.2024.116873 · Cited by 6
Zhang, Z., Kasai, S., Sakaniwa, K., Fujimura, A., Ohto, U., & Shimizu, T. (2024) · Structure · doi:10.1016/j.str.2024.11.019 · Cited by 7
Zimmermann, M., Kappert, K., & Stan, A. C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.046 · Cited by 6
Talluri, R. S., Gaudana, R., Hariharan, S., & Mitra, A. K. (2009) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s2857 · Cited by 6
Qu, F., Tang, J., Hu, R., Hao, G., Zhou, Y., Lu, S., Zhao, Q., You, C., Li, Y., Zhou, Z., et al. (2017) · Aquaculture Nutrition · doi:10.1111/anu.12630 · Cited by 7
Drug Transporters and Their Role in Tissue Distribution
Dantzig, A. H., Hillgren, K. M., & de Alwis, D. P. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39021-4 · Cited by 7
Nutrient Digestion, Absorption, and Sensing
Bishu, S., & Quigley, E. M. M. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch29 · Cited by 7
Warashina, S., Sato, H., Zouda, M., Takahashi, M., Wada, Y., Passioura, T., Suga, H., Watanabe, Y., Matsumoto, K., & Mukai, H. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01020 · Cited by 5
Park, J. B. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120280 · Cited by 5
Angiotensin converting enzyme inhibitory activity of amino acid esters of carbohydrates
Kamath, V. G., Rajini, P. S., Lohith, K., Somashekar, R., & Divakar, S. (2006) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2006.01.008 · Cited by 5
Lack of Interaction Between the Peptidomimetic Substrates Captopril and Cephradine
Foster, D. R., Yee, S., Bleske, B. E., Carver, P. L., Shea, M. J., Menon, S. S., Ramachandran, C., Welage, L. S., & Amidon, G. L. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008329554 · Cited by 5
El‐Kattan, A. F. (2017) · doi:10.1002/9781118916926.ch4 · Cited by 5
Roy, T., Nath, M., Halder, N., Saxena, R., & Velpandian, T. (2025) · The Journal of Membrane Biology · doi:10.1007/s00232-025-00348-1 · Cited by 5
“PEPT1 and PEPT2 facilitate the absorption of nearly all di-and tripeptides, along with numerous peptidomimetics such as β-lactam antibiotics (Terada and Inui 2004; Huh 2013), anticancer drugs (Brecht et al. 2020; Wang et al. 2022), pho-tosensitizing agents (5-aminolevulinic acid) (Xiang et al.…”
Szabó, Z. R., Xia, J., Mathews, W. B., & Brown, P. R. (2006) · PubMed Central · doi:10.1053/j.semnuclmed.2005.08.00 · Cited by 4
“They are also involved in the transport of orally active peptide-like drugs such as the beta-lactam antibiotics, bestatin, ACE inhibitors and renin inhibitors (39,40).”
BackgroundTransport of nonessential metals across mammalian cell membranes
Ballatori, N., & Madejczyk, M. S. (2005) · Topics in current genetics · doi:10.1007/4735_102 · Cited by 6
Mechanisms of Drug Interactions II: Transport Proteins
Moss, D. M., Siccardi, M., & Marzolini, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-72422-5_3 · Cited by 4
Artificial Tyroserleutide Transporters for Synergistic Cancer Therapy
Luo, D., Jia, C., Zhu, X., Zhou, J., Li, P., Wan, J., Yang, Q., Ding, R., Gao, X., Zeng, Z., et al. (2025) · JACS Au · doi:10.1021/jacsau.5c00204 · Cited by 3
Deb, S., & Borah, A. (2024) · PharmaNutrition · doi:10.1016/j.phanu.2024.100419 · Cited by 3
Anatomy and Physiology of the Biliary Epithelium
Kanz, M. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01004-6 · Cited by 5
Moustafa, H. A. M., Elsakka, E. G. E., Abulsoud, A. I., Elshaer, S. S., Rashad, A. A., El‐Dakroury, W. A., Sallam, A.-A. M., Rizk, N. I., Zaki, M. B., Gomaa, R. M., et al. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114234 · Cited by 3
Energetics of substrate transport in proton-dependent oligopeptide transporters
Selvam, B., Chiang, N., & Shukla, D. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01398-7 · Cited by 2
Effect of Orange Oil on the Oral Absorption of Enrofloxacin in Rats
Lim, J., Kim, M.-S., Hwang, Y., Song, I.-B., Kim, T., & Yun, H. (2012) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.61.71 · Cited by 2
Molecular Fields to Assess Recognition Forces and Property Spaces☆
Vistoli, G., & Pedretti, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12659-9 · Cited by 2
Park, J. B. (2021) · Current Nutraceuticals · doi:10.2174/2665978603666211224121836 · Cited by 2
Pharmacogenetics of SLCO1B1 : Population genetics and effect on statins
Pasanen, M. K. (2008) · Työväentutkimus Vuosikirja · Cited by 5
Role of proton-coupled oligopeptide transporters in small peptide absorption and disposition
Jappar, D. (2009) · Deep Blue (University of Michigan) · Cited by 2
Natural Antihypertensive Peptides: Emerging Therapeutics for Blood Pressure Management
Varungase, A. T., & Shinde, N. V. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3410 · Cited by 1
Oral absorption basics: pathways, physicochemical and biological factors affecting drug absorption
Zhu, L., Lu, L., Wu, J., Shi, J., Yan, T., Xie, C., Li, Q., Liu, Z., & Hu, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34156-4.00019-4
Landscape for oral delivery of peptides
Jackman, M. J., Davies, N. M., Bak, A., & Puri, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821061-1.00001-0 · Cited by 2
Wang, W., Li, F., Gan, S., Fan, J., Jiang, Q., & Zhang, T. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124017 · Cited by 1
Impact of Drug Transport Proteins
Terada, T., & Inui, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3_23 · Cited by 2
Self-citationCarl, S. M., Herrera‐Ruiz, D., Bhardwaj, R. K., Gudmundsson, O. S., & Knipp, G. T. (2014) · doi:10.1002/9781118705308.ch5 · Cited by 1
Solute Carrier (SLC) Transporters: An Overview
Talevi, A., & Bellera, C. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-84860-6_83 · Cited by 1
Pharmacokinetic interactions affecting the antidiabetic repaglinide
Kajosaari, L. I. (2006) · Työväentutkimus Vuosikirja
Momper, J. D. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Étude et modélisation de la cinétique orale de l'amoxicilline chez le porcelet
Bernier, D. (2008) · doi:10.71781/3790 · Cited by 4
Lockwood, C. M. (2010) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 2
Role of basolateral efflux transporters in intestinal absorption of drugs and prodrugs
Ming, X. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ckzf-bd14
Anatomy and Physiology of the Biliary Epithelium
Hall, C. M., Glaser, S. S., & Alpini, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95660-5
MAMMALIAN OLIGOPEPTIDE TRANSPORTERS
Carl, S. M., Herrera‐Ruiz, D., Bhardwaj, R., Gudmundsson, O. S., Mowery, S. A., & Knipp, G. T. (2022) · doi:10.1002/9781119739883.ch6
Solute Carrier (SLC) Transporters: An Overview
Talevi, A., & Bellera, C. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_83-1
A biopharmaceutics perspective on oral peptide developability and drug delivery
Ganesh, A. N., Garad, S., & Sánchez-Félix, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821061-1.00009-5 · Cited by 1
Khatami, S. H., Karima, S., Kondori, B. J., Sepandi, M., & Jangravi, Z. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2790
“Additionally, they can be easily embedded in biological carriers for delivery to target tissues/cells [22].”
Anatomy and Physiology of the Biliary Epithelium
Hall, C., Glaser, S. S., & Alpini, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.01004-4
Transporter; 3. Clinical Pharmacokinetic Roles of Peptide Transpoters (PEPT1 and PEPT2)
寺田, 智. (2004) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.35.2_61
Zhao, Y., Chen, D., Tian, G., Zheng, P., Pu, J., & Yu, B. (2026) · Animal nutrition · doi:10.1016/j.aninu.2025.12.022
Metadata
- Authors
- Terada, T., & Inui, K.-I.
- Affiliations
- Kyoto University (JP)
- Kyoto University Hospital (JP)
- Corresponding author
- Inui, Ken-ichi
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-02-01
- Volume
- 5
- Issue
- 1
- Pages
- 85-94
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W138900185
- Cited by
- 177
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 9 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 12
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- peptide transporters, PepT1, PEPT2, drug delivery, valacyclovir, intestinal epithelium, renal epithelium, brush border membrane, basolateral membrane, beta-lactam antibiotics, structure-function relationship, transporter regulation, amino acid uptake
- MeSH terms
- Peptide Transporter 1, Animals, Biological Transport, Carrier Proteins, Pharmaceutical Preparations, Humans, Organ Specificity, Peptides, Pharmacokinetics, Protein Conformation, Symporters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.